You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Very Low Density Lipoprotein Receptor (VLDLR) Antibodies

The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Additionally we are shipping VLDLR Kits (42) and VLDLR Proteins (8) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
VLDLR 7436 P98155
VLDLR 22359 P98156
VLDLR 25696  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-VLDLR Antibodies at antibodies-online.com

Showing 10 out of 70 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated FACS, IHC (p), WB VLDLR Antibody (Center) (ABIN651940) western blot analysis in 293 cell line lysates (35 µg/lane). This demonstrates the VLDLR antibody detected the VLDLR protein (arrow). VLDLR Antibody (Center) (ABIN651940) immunohistochemistry analysis in formalin fixed and paraffin embedded human skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining 400 μL Log in to see 10 to 11 Days
$324.50
Details
Human Rabbit Un-conjugated IF (p), IHC (p), WB Antigen: 0.2 µg/100 µL Primary: Antiserum, 1:500, 1:1000, 1:2000, 1:4000, 1:8000, 1:16000, 1:32000; Secondary: HRP conjugated Goat Anti-Rabbit IgG at 1: 5000; TMB staining; Read the data in Microplate Reader by 450nm Formalin-fixed and paraffin embedded mouse embryo labeled with Anti-VLDL Polyclonal Antibody, Unconjugated (ABIN705551) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL Log in to see 3 to 7 Days
$269.50
Details
Human Mouse Un-conjugated EIA, WB   0.2 mg Log in to see 6 to 8 Days
$401.50
Details
Human Mouse Un-conjugated EIA   0.2 mg Log in to see 6 to 8 Days
$357.50
Details
Human Mouse Un-conjugated EIA, WB   0.2 mg Log in to see 6 to 8 Days
$489.50
Details
Human Rabbit Un-conjugated ELISA   100 μg Log in to see 16 Days
$163.90
Details
Human Mouse Un-conjugated IHC (p), ELISA, WB Anti-VLDLR antibody IHC staining of human brain, cerebellum, Purkinje. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody  ABIN1105002 dilution 1:50. 250 μg Log in to see 8 to 10 Days
$451.00
Details
Human Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 11 to 13 Days
$365.20
Details
Human Rabbit APC FACS, IHC, ELISA, WB   200 μL Log in to see 8 to 10 Days
$969.83
Details
Human Mouse Un-conjugated ELISA   100 μg Log in to see 16 Days
$218.90
Details

VLDLR Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
,
,
, , , , , , , , , , , , , ,
Mouse (Murine) ,


, , , , , , , , , , , ,
Rat (Rattus) ,
,
,
, , , , , , , , , , , ,

Top referenced anti-VLDLR Antibodies

  1. Human Polyclonal VLDLR Primary Antibody for ELISA - ABIN1998173 : Trommsdorff, Gotthardt, Hiesberger, Shelton, Stockinger, Nimpf, Hammer, Richardson, Herz: Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. in Cell 1999 (PubMed)
    Show all 5 references for ABIN1998173

  2. Human Polyclonal VLDLR Primary Antibody for FACS, IHC (p) - ABIN651940 : Sakai, Tiebel, Ljungberg, Sullivan, Lee, Terashima, Li, Kobayashi, Lu, Chan, Oka: A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins. in Brain research 2009 (PubMed)
    Show all 2 references for ABIN651940

  3. Human Monoclonal VLDLR Primary Antibody for EIA - ABIN263866 : Ruiz, Kouiavskaia, Migliorini, Robinson, Saenko, Gorlatova, Li, Lawrence, Hyman, Weisgraber, Strickland: The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. in Journal of lipid research 2005 (PubMed)

  4. Human Polyclonal VLDLR Primary Antibody for IF (p), IHC (p) - ABIN705551 : Fredriksson, Mishra, Lam, Mushaben, Cuento, Meyer, Yao, Keeran, Nugent, Qu, Yu, Yang, Raghavachari, Dagur, McCoy, Levine: The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. in Journal of immunology (Baltimore, Md. : 1950) 2014 (PubMed)

More Antibodies against VLDLR Interaction Partners

Human Very Low Density Lipoprotein Receptor (VLDLR) interaction partners

  1. These results for the first time demonstrated that SalA protected against IS/RP-induced endothelial barrier dysfunction through suppression of VLDL receptor expression

  2. these results suggest that VLDLR functions in vivo as an HCV receptor independent of canonical CD81 (show CD81 Antibodies)-mediated HCV entry.

  3. the results obtained indicate that minimal fibrin-binding structures are located within the second and third CR domains of the VLDL receptor and the presence of the fourth CR domain is required for high-affinity binding

  4. The results of this study demonstrated the presence of reelin (show RELN Antibodies), its receptors VLDLR and ApoER2 (show LRP8 Antibodies) as well as Dab1 (show DAB1 Antibodies) in the ENS and might indicate a novel role of the reelin (show RELN Antibodies) system in regulating neuronal plasticity and pre-synaptic functions in the ENS.

  5. these results suggested that the miR (show MLXIP Antibodies)-135a-VLDLR-p38 (show CRK Antibodies) axis may contribute to gallbladder cancer cell proliferation

  6. study identified a novel homozygous VLDLR c.2248C>T mutation (p.Q750X) and distinctive MRI (show C7ORF49 Antibodies) findings in 2 siblings with ataxia (show USP14 Antibodies); also marked vitamin E deficiency was detected in the proband

  7. these results identify a novel role for the VLDLR as a negative regulator of DC-mediated adaptive immune responses in HDM (show HDAC3 Antibodies)-induced allergic airway inflammation.

  8. ectopic expression of HIC1 (show HIC1 Antibodies) in U2OS and MDA-MB-231 cell lines decreases expression of the ApoER2 (show LRP8 Antibodies) and VLDLR genes, encoding two canonical tyrosine kinase (show TXK Antibodies) receptors for Reelin (show RELN Antibodies).

  9. an unusual constellation of VLDLR mutations in Cerebellar ataxia (show USP14 Antibodies), mental retardation and dysequilibrium syndrome 1 is reported

  10. Results show variation in VLDLR is implicated in disordered gambling

Mouse (Murine) Very Low Density Lipoprotein Receptor (VLDLR) interaction partners

  1. The absence of PCSK9 (show PCSK9 Antibodies) results in a sex- and tissue-specific subcellular distribution of the LDLR (show LDLR Antibodies) and VLDLR, which is determined by estradiol levels.

  2. In the retinas of Vldlr(-/-) mice with low fatty acid uptake but high circulating lipid levels, we found that Ffar1 (show FFAR1 Antibodies) suppresses expression of the glucose transporter Glut1 (show SLC2A1 Antibodies)

  3. neuronal stress differentially regulates lipoprotein receptor expression in neurons, with VLDLR upregulation as a common element as a modulator of neuronal Wnt (show WNT2 Antibodies) signaling

  4. Subretinal vascularization (SRV) in the Vldlr-/- model is associated with mistargeted neurites and that SRV is preceded by altered retinal vascular development.

  5. VLDLR requires RasGRF1 (show RASGRF1 Antibodies)/CaMKII (show CAMK2G Antibodies) to alter dendritic spine formation.

  6. This study demonstrated that VLDLR is expressed in distinct spatiotemporal patterns in developing mouse cerebral cortex.

  7. LRP5 (show LRP5 Antibodies) signaling is a prerequisite for neovascularization in VLDLR knockout mice. LRP5 (show LRP5 Antibodies) may be an effective target for inhibiting intraretinal neovascularization.

  8. these results identify a novel role for the VLDLR as a negative regulator of DC-mediated adaptive immune responses in HDM (show HDAC3 Antibodies)-induced allergic airway inflammation.

  9. Nuclear factor (erythroid-derived 2)-like 2 (show NFE2L2 Antibodies) activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.

  10. Clusterin (show CLU Antibodies) is a ligand for apolipoprotein E receptor 2 (ApoER2 (show LRP8 Antibodies)) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin (show RELN Antibodies)-signaling pathway.

VLDLR Antigen Profile

Protein Summary

The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene.

Gene names and symbols associated with VLDLR

  • very low density lipoprotein receptor (VLDLR) antibody
  • very low density lipoprotein receptor (Vldlr) antibody
  • very low density lipoprotein receptor-like (LOC100343584) antibody
  • AA408956 antibody
  • AI451093 antibody
  • AW047288 antibody
  • CARMQ1 antibody
  • CHRMQ1 antibody
  • VLDLRCH antibody

Protein level used designations for VLDLR

VLDL receptor , VLDL-R , very low-density lipoprotein receptor , VTG receptor , very low density lipoprotein (VLDL)/vitellogenin receptor , vitellogenin receptor

GENE ID SPECIES
7436 Homo sapiens
22359 Mus musculus
396154 Gallus gallus
25696 Rattus norvegicus
100725662 Cavia porcellus
733630 Sus scrofa
100008976 Oryctolagus cuniculus
476336 Canis lupus familiaris
282123 Bos taurus
101117143 Ovis aries
100343584 Oryctolagus cuniculus
Selected quality suppliers for anti-VLDLR (VLDLR) Antibodies
Did you look for something else?